Recombinant Albumin and Hyaluronic Acid, Preferred Biomaterials for Biomedical and Pharmaceutical Applications

摘要

Novozymes has developed the innovative recombinant ingredients Hyasis~® and Albucult~® to address the challenges associated with existing sources for these ingredients. Relying on state-of-the-art technologies in each field, these materials display unsurpassed purity, consistency and performance and offer great promise for use in biomedical applications.